Background：We have shown that extracellular matrix (ECM) rather than cell proliferation contributes to in-stent restenosis. Transforming growth factor-β (TGF-β), a positive regulator of ECM deposition by vascular cells, may be implicated in in-stent restenosis. We assessed if the blockade of TGF-β by catheterbased local delivery of an adenovirus expressing a soluble form of TGF-β type II receptor (AdTβ-ExR) can inhibit stent-induced neointima. Methods：AdTβ-ExR was applied onto a coronary arterial segment of a pig using an Infiltrator
Introduction
Neointimal ingrowth rather than tissue remodeling or stent recoil is thought to play a key role in restenosis after stenting. 1) Studies of human coronary in-stent neointima suggest that the enhanced ECM accumulation may be an important mechanism for the development of in-stent neointima.
2)
The TGF-β expression is thought to increase ECM accumulation. The level of TGF-β1 mRNA is increased in arteries as early as 6 hours after injury, 3) and its expression is significantly higher in restenotic lesions compared with primary lesions. 4) TGF-β1 up-regulates the synthesis of various ECM components, such as proteoglycans, hyaluronan, fibronectin, and collagen.
3) [5] [6] [7] [8] TGF-β1 also enhances ECM accumulation by downregulating plasminogen activators as well as by increasing the plasminogen activator inhibitor. 4)5) Direct evidence showing that TGF-β1 is involved in the development of arterial lesion was reported. [6] [7] [8] Over-expres-sion of the TGF-β1 promotes the formation of a neointima enriched with ECM, 6)7) and withdrawal of TGF-β1
contributes to neointimal regression with increased apoptosis. 7) Treatment of balloon injured arteries with neutralizing anti-TGF-β1 antibodies reduced intimal hyperplasia. 8) In contrast, other studies suggested the role of TGF-β in inhibition of inflammation and atherosclerosis. 9) Most cells express three types of TGF-β receptors (type I, II and III) on the surface, and type I and II receptors (TβRI and TβRII, respectively) are necessary for all biological activity of TGF-β. 10 )11) TGF-β exerts its effect by binding to heterodimeric complexes of TβRI and TβRII. 10)11) TβRII is a transmembrane receptor of serine-threonine kinase family, and can itself bind free TGF-β, whereas TβRI can only recognize TGF-β that is already bound with TβRII. 11) An adenoviral vector expressing the ectodomain of TβRII (AdTβ-ExR) specifically inhibits the function of the endogenous TβRII, and inhibits action of TGF-β, specifically TGF-β1, TGF-β3, and TGF-β5, but not TGF-β2. 12)13) AdTβ-ExR can act as a specific dominant negative mutant of TβRII, thus preventing an interaction of the endogenous functional TβRII with TβRI. 10) In this study, we inhibited TGF-β using a catheter based local in vivo delivery of AdTβ-ExR in a porcine coronary stent model. Blockade of TGF-β did not reduce in-stent neointima formation, although it did reduce ECM formation to some extent. Furthermore, blockade of TGF-β induced increases in T cell infiltration, MMP 1 expression, deposition of hyaluronan-rich ECM, and medial cell proliferation rate, suggesting that inhibition of TGF-β activity promotes inflammation in injured arteries.
Methods

Materials
Antibodies against soluble human TβRII IgG (a fluorescein isothiocyanate (FITC)-conjugated, rabbit polyclonal), human CD3 (T cell marker, rabbit polyclonal), human α-actin (SMC marker, mouse monoclonal), and human proliferating cell nuclear antigen (PCNA)(cell proliferation rate marker, mouse monoclonal) were purchased from Dako, Carpinteria, CA. Mouse monoclonal anti-human MMP1 and rabbit polyclonal anti-porcine TGF-β1 were purchased from Oncogene, Cambridge, MA and Cell Sciences, Norwood, MA, respectively. Biotinylated anti-mouse IgG and antirabbit IgG were purchased from Dako. The Vectastain Eite ABC kit (Avidin DH and biotinylated horse-radish peroxidase H reagent) was purchased from Vector Lab., Burlingame, CA. DAB (3, 3'-diaminobenzidine tetrahydrochloride) and other chemicals were purchased from Sigma (St. Louis, MO).
Recombinant adenovirus vector
Replication-defective E1-and E3-recombinant adenovirus expressing either an entire ectodomain of the TGF-β type II receptor fused to the human immunoglobulin Fc portion (AdTβ-ExR) or β-galactosidase (AdLacZ) under a CA promoter (composed of cytomegalovirus enhancer and chicken β-actin promoter) was constructed as described previously. 14) AdTβ-ExR-infected cells secrete soluble TGF-β type II receptor (TβRII), which inhibits TGF-β signaling by binding TGF-β. 13) Adenovuruses were propagated and titered in HEK 293A cells, and were prepared by ultracentrifugation in cesium chloride gradient to yield concentrations of the order of 10 9 -10 10 plaque forming unit (pfu).
Local intravascular gene delivery and stent deployment
A total of thirteen large white female pigs (2-3 mo, 25-30 kg) were used for this study. Ten pigs underwent coronary artery intravascular gene delivery with subsequent intracoronary stent deployment. Briefly, animals took 100 mg/d Aspirin and 75 mg/d Clopidogrel 24 hours prior to the procedure and continued to take these until sacrifice. Before anesthesia, pigs subjected to intramuscular injection of Atropine (0.04 mg/Kg), Xylazine (2 mg/Kg), and Ketamine (10 mg/Kg). Anesthesia was induced by inhalation of 2.5% Enflurane.
Heparin 6,000 IU was injected intravenously, and an 8 F Judkins right coronary artery (RCA) guide catheter was inserted through the left carotid artery. Two coronary arterial segments feasible for intravascular delivery using a 3.0-3. 5 one embedded in OCT for cryostat sectioning and the other kept -70℃ until RNA assay. The stented arterial specimens were pressure-fixed in situ with 4% formaldehyde, excised from the porcine heart, and divided into two segments by cutting the bridge portion of the Palmaz-Schatz stent. One bisected arterial specimen with higher degree of stenosis underwent tissue processing with Kulzer Histotechnik 8100 (Heraeus Kulzer, Germany) for morphometric analysis, and the other bisected specimen was embedded int paraffin for pathological staining.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from each arterial segment was isolated using RNeasy mini kit (Qiagen, Germany). Total cDNA synthesized from 2 μg of total RNA was amplified for 35 cycles at 94℃ for 30 s, 54℃ for 1 min, and 72℃ for 1 min. The primer sets for TβRII (5'-ACA TCG TCC TGT GGA CGC GTA-3' and 5'-CTA GCA ACA AGT CAG GAT TGC-3'), or 28S rRNA (5'-TTA AGG TAG CCA AAT GCC TCG-3', and 5'-CCT TGG CTG TGG TTT CGC T-3') were used for amplification of 450 bp and 102 bp fragments, respectively. Similarly, total RNA was isolated from the adenovirus-infected (6 and 60 moi) cultured rat arterial smooth muscle cells using Trizol (Gibco, Grand Island, NY) to study the effect of AdTβ-ExR on the expression of connective tissue growth factor (CTGF) mRNA. The PCR primer sets for CTGF (5'-CGC CTG TTC TAA GAC CTG T-3' and 5'-GAA AGC TCA AAC TTG ACA GG-3') and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5'-TCA TTG ACC TCA ACT ACA TGG T-3' and 5'-CTA AGC AGT TGG TGG TGC AG-3') were used for amplification of 420 bp and 370 bp fragments, respectively. PCR products were separated on a 1.2% agarose gel, stained with ethidium bromide, and analyzed using an image analyzer (Bioprofil, Viber Lourmat, France).
Immunohistochemical staining
Imunohistochemical staining was done on serial sections as described previously.
2) Briefly, after deparaff- Movat pentachrome stain 16) was used to identify ECM components. Collagen was identified in the picrosirius red-stained sections from paraffin-embedded tissue with polarized light on Olympus BX51 light microscope.
The proportional area of either collagen or hyaluronan in each vessel layer was measured by analyzing at least 3 microscopic fields (×100) with Optimas 6.5 image software. To estimate semi-quantitatively the extent of distribution of CD3 positive T cells, we categorized the extent of T cells into three scores: one for CD3 positive cells <10% of total cells, two for ≥10% and <50%, three for >50%.
Statistical analysis
All data are expressed as mean±SD, and all sta- 
Results
Identification of the infected human TβRII gene
Two coronary arterial segments, proximal and distal left anterior descending artery (LAD), from a pig were injected with two different titers of AdTβ-ExR. One week after gene delivery, the levels of mRNA or protein of TβRII were determined from each arterial segment. As shown in Figure 1 
The effect of AdTβ-ExR on CTGF mRNA in cultured rat arterial SMCs
There are CTGF-dependent and CTGF-independent signaling pathways activated by TGF-β, and CTGF functions as a downstream mediator of TGF-β in fibroblastic cells. 17) We analyzed to know if the expression of CTGF mRNA in cultured rat arterial SMCs can be affected by either AdTβ-ExR or AdLacZ. The expression of CTGF mRNA was inhibited by AdTβ-ExR at moi 60( Figure 2 ). Therefore AdTβ-ExR can downregulate CTGF expression, thereby inhibiting ECM synthesis.
The effect of blockade of TGF-β on morphometric parameters
Seven pairs(AdTβ-ExR and control group) of coronary arteries from seven pigs were analyzed for the comparison of morphometric parameters, as summarized in Table 1 . Both AdLacZ and PBS treated arteries were pooled together as a control group. Cell density of neointima was significantly greater in the AdTβ-ExR group than in control group (3,121±331 vs 2,812±183 cells/ mm 2 , p<0.05). However there was no significant difference in lumen area, intima area, percent area stenosis, area ratio of intima to media, or adventita area between the AdTβ-ExR and control group. Hyaluronan detected with hyaluronan binding protein was expressed moderately in neointima of control artery (J), however its expression in AdTβ-ExR artery was more abundant in around neointima and adventitia enriched with inflammatory cells (K, L). Expression of MMP1 was localized in neointima and media of control artery (M), on the contrary its expression in AdT β-ExR artery was also additionally found in inflammatory cell-rich adventitia (N, O). *: marks the site of higher magnification. NI: neointima, M: media, A: adventitia, PRA: proximal reference artery, HA: hyaluronan. counterstaining with hematoxylin. AdTβ-ExR: adenoviral vector expressing the ectodomain of the type II TGF-βreceptor, AdLacZ: adenovirus expressing β-galactosidase, TGF-β: transforming growth factor-β, ECM: extracellular matrix, MMP1: matrix metalloproteinase 1. Bars=100 μm.
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The effect of blockade of TGF-β on pathological characteristics
Infiltration of inflammatory cells was more marked in the AdTβ-ExR group compared with control group as shown in Figure 3 (A, B) . The inflammatory cells were present throughout the tissue, but accumulated especially at around stent struts and adventitia ( Figure  3C ). Immunohistochemical staining identified CD3 positive T cells as the main component of inflammatory cells (Figure 3D-F) , while the rest were composed of macrophages, eosinophils, and multinucleated giant cells ( Figure 3C ). T cell distribution in the AdTβ-ExR group was significantly larger than that of control group ( Figure  4) . In general, α-actin positive smooth muscle cell (SMC) was the predominant cell type in neointima and media of both groups, and most of these SMCs were TGF-β1 positive by immunohistochemical staining (figure not shown).
Movat staining identified that glycosaminoglycans were the predominant ECM component in the in-stent neointima in both AdTβ-ExR and control groups ( Figure 3G, H) . Hyaluronan, detected by hyaluronan binding protein, was abundantly expressed in stented arteries ( Figure 3J, K) , whereas its expression was scarce in proximal reference artery. The accumulation of hyaluronan was diffuse and variable, but tended to be increased in neointima especially near the stent strut and in adventitia containing many inflammatory cells Figure  5 ). Polarizing microscopy on picrosirius-red stained slides was used to estimate collagens content. Areas of collagen in all three layers were not significantly different between the AdTβ-ExR and control group. (figure not shown). The expressions of MMP1 in neointima and media were similarly increased in both AdTβ-ExR and control groups, however its expression in adventitia tended to be higher in the AdTβ-ExR group containing many inflammatory cells (Figure 3M-O) .
Cell proliferation rate, as measured by PCNA index (PCNA positive cells/total cells (×100 (%)), was increased in the media of the AdTβ-ExR group compared with that of control group (2.04±1.21% vs 1.18±
1.06%, p<0.05), however there was no significant difference in intimal cell proliferation rate between two groups ( Figure 6 ).
Discussion
Blockade of TGF-β did not alter neointima area in a pig in stent model of restenosis. On the other hand, a key determinant of stent restenosis, ie vascular inflammation was affected. An increase in cell density without any area change shown in neointima of arteries treated with TGF-β blockade probably reflect modest decrease in ECM formation. If an inhibition of ECM accumulation was the sole mechanism by blockade of TGF-β, then less neointimal area with higher cell density, compared with control group, would be an expected outcome. Pathological analysis of stented arteries treated with TGF-β blockade showed increases in hyaluronanrich ECM and in MMP1 expression in association with T cell infiltration, all of which could promote cell migration and, together with an increase of medial cell proliferation rate, lesion growth. These findings illustrate why blockade of TGF-β by gene transduction promotes or does not change rather than inhibits events associated with neoinitmal growth in stent restenosis.
An increase in T cell infiltration was observed especially at around adventitia and stent strut in the AdTβ-ExR group, in which MMP1 tended to be highly expressed. At least three factors in our experiment, such as adenoviral vector, 18) angioplasty induced vascular injury, 19) and inhibition of TGF-β signaling, 9)20) could induce inflammation. Adenoviral gene delivery can induce host cellular and humoral immune response and dose-dependent inflammation, which in turn can adversely affect gene expression. 18) Inflammation also tends to be aggravated with high degree of vascular injury. 19) However the significance of TGF-β blockade probably outweighs other factors in our study, since the infiltrated T cells were much more in the AdTβ-ExR group compared with control group. Our data supports the notion that TGF-β has an anti-inflammatory property. Hyaluronan is a high molecular weight polysaccharide, and is implicated in various biological processes including cell migration and proliferation, tumor invasion, angiogenesis, and wound healing. 21) Hyaluronan, found in human in-stent neointima especially at early period (<6 mo) after stenting, 2) can serve as a sustrate for leukocytes and promote leukocyte adhesion and therefore can be considered a proinflammatory component of ECM. Hyaluronan may significantly contribute to the formation of neointima 21) and vascular remodeling 22) after angioplasty. and on a Apo E deficient artery. 9) But its effect on stent restenosis is not known well yet. Interference of TGF-β inhibited loss of lumen area in balloon injured arteries mainly by decreasing negative vascular remodeling.
12)26)
However the effect of inhibition of TGF-β on the newly developed lesion area was diverse: a decrease in, 8) 12) no significant change in, 26) or an increase in lesion size. 9) In addition, the effects of blockade of TGF-β on adventitial collagen area are also contradictory. An increase in collagen content was noted in porcine coronary arteries, 26) whereas a decrease was observed in rat carotid arteries.
12)
The exact causes for the discrepancies in neointima area, collagen content, inflammation profiles, and proliferation rates in ours and other studies are not clear. As a possible factor to explain these discrepancies, a context dependent property of TGF-β should be in consideration. TGF-β exerts bifunctional effects that are dependent upon the context, in which the particular cell encounters the TGF-β signaling. 27) In our data, cell proliferation rate of the AdTβ-ExR group was significantly increased, compared with control group, in media. TGF-β can affect cell proliferation differently at different settings. TGF-β1 inhibits cell proliferation either by extending G2 phase or by arresting in G1 phase. 28) But other in vitro data showed that cell proliferation was affected in a different way by different doses of TGF-β1. 29) Data of other in vivo studies are also confusing. Either exogenous infusion of TGF-β1 3) or adenovirus mediated TGF-β1 transfection 7) increased cell proliferation rate in rat neointima. However, similar to our study, inhibition of TGF-β signaling tends to increase, though not significant, cell proliferation rate in intima of balloon injured artery. 12) SMC proliferation can also be affected by degradation of collagen. Human newborn arterial SMCs plated on monomeric type I collagen proliferate in responding to platelet-derived growth factor, whereas SMCs grown on polymerized type I collagen are arrested in the G1 phase of the cell cycle owing to upregulation of cyclin dependent kinase 2 inhibitors. 30) Therefore enhanced MMP1 expression in the AdTβ-ExR group might promote degradation of collagen, which in turn could increase cell proliferation rate.
Our experiment has other several limitation factors. Drug delivery using an Infiltrator TM may induce a vascular injury causing dissection, intramural thrombosis, and vasospasm. In addition, host immune response and dose-dependent inflammatory and cytopathic effects can inhibit adenoviral gene delivery and target gene expression. 18) Therefore these methodological problems might affect vascular tissue response, thus may complicate the interpretation of the effects of inhibition of TGF-β.
In conclusions, blockade of TGF β signaling using a catheter-based gene transfer of a soluble TβRII could not inhibit in-stent neointima formation, although it reduced ECM formation modestly. Pathological property characterized by increases in T cell infiltration, MMP1 expression, medial cell proliferation, and ECM enriched with hyaluronan, induced by blockade of TGF-β, might contribute to lesion progression and offset modest benefit provided by inhibition of ECM formation.
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